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To offer an overview of current data on available
endoscopic techniques used for patients with GI bleeding
resulting from DL.
The articles published during the years 2015-
2020 from the PubMed database were selected
according to the following keywords: “Dieulafoy’s
lesion”, “Endoscopic hemostasis”, “Mechanical
hemostatic techniques”, “Endoscopic band
ligation”, “Endoscopic hemoclipping”.
Each endoscopic method has both advantages and
disadvantages, however, mechanical therapies
including endoscopic hemostatic clipping (EHC)
and band ligation (EBL) are considered to be the
first option in the bleeding control with a success
rate of about 90% [8]. Studies also show that
patients treated with EHC and EBL have lower
potential of recurrent bleeding with a lower
mortality rate and excellent long-term results.
However, there have been few studies comparing
the efficacy of different mechanical methods in
treating DL.
Several years ago, a meta-analysis of clinical
trials examining this issue demonstrated that there
is NO clear benefit and NO differences in clinical
outcomes between the EHC group vs EBL group [2].
However, due to a shorter procedure time, EBL is
recommended as initial hemostatic method [9].
Mechanical hemostatic therapy demonstrated
good clinical outcomes compared with other
endoscopic techniques and is recommended as
effective option in patients with DL.
Results
Fig. 1: Georges Dieulafoy 
(1839–1911)
Dieulafoy's lesion (DL) is said to be a rare pathology. Even
so, it is an important potentially fatal source of
gastrointestinal bleedings (GIB), accounting for up to 5% of
acute nonvariceal GIBs and mortality of bleeding – 9%-
13%. So, it is necessary to include this pathology in the
differentiated pathology of obscure GIB [1].
DL is characterized by the presence of an abnormally
large dilated vessels that fail to decrease in size while
emerging from the submucosa to the mucosal surface
within the gastrointestinal wall or respiratory tract [2, 3].
About 75% of lesions are located in the stomach.
However, lesions can also occur in the esophagus,
duodenum, jejunoileum, colorectum, and even bronchus [4,
5, 6]. So, depending upon the location of the lesion, it may
cause upper, middle or lower GIB. Obviously, even today DL
is considered a challenging diagnosis [7].
Being a rare pathology, bleeding often requiring rapid
diagnosis and treatment that may vary depending on lesion
locations, there is no universal consent about the diagnosis
and treatment approach (clips, sclerotherapy, argon plasma
coagulation, thermocoagulation, or electrocoagulation)[6].
Fig. 2 Gastric DL[4]
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